Evidence map›Paper›PMID 41828350›Full record

ArticleInternational journal of molecular sciences2026

MFF-AE: Enhanced Quality Control for Proteomics Mass Spectrometry Data via Multi-Scale Feature Fusion.

Guangkui Fan, Xinyu Ji, Hunyue Liao, Bo Meng, Duotao Pan, Jinze Huang, Yang Zhao

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guangkui FanCollege of Information, Shenyang University of Chemical Technology, Shenyang 110142, China.ORCID 0009-0007-1299-9906
Xinyu JiTechnology Innovation Center of Mass Spectrometry for State Market Regulation, Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Hunyue LiaoTechnology Innovation Center of Mass Spectrometry for State Market Regulation, Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Bo MengTechnology Innovation Center of Mass Spectrometry for State Market Regulation, Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Duotao PanCollege of Information, Shenyang University of Chemical Technology, Shenyang 110142, China.
Jinze HuangTechnology Innovation Center of Mass Spectrometry for State Market Regulation, Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.ORCID 0000-0002-9066-987X
Yang ZhaoCollege of Information, Shenyang University of Chemical Technology, Shenyang 110142, China.ORCID 0000-0003-1444-5927

Funding

National Key R&D Program of China 2022YFF0608404, 2022YFF0705001, 2022FY101202National Natural Science Foundation of China Nos 21927812Plan for Leading Talents of Science and Technology Innovation No.WR2202Research Project of the National Institute of Metrology AKYZD2111
6 · The paper itself

Abstract

Mass spectrometry (MS) is a core analytical tool in proteomics, and the quality of the generated data directly determines the effectiveness of downstream analyses and the reliability of final research conclusions. While MS is also widely used in other omics applications, this study focuses on label-free quantitative proteomics, where samples are represented as protein-abundance matrices derived from MaxQuant. However, MS data are typically characterized by high dimensionality and substantial noise, posing serious challenges for quality control (QC). Existing QC methods have limited feature extraction capabilities and struggled to capture the key information embedded in the data, resulting in poor performance in identifying anomalous samples. Here, we propose the Multi-Scale Feature Fusion-based Autoencoder (MFF-AE). This deep learning-based anomaly detection model achieves precise identification of anomalous samples by integrating both global and local data features. The model consists of three modules: an autoencoder-based backbone network that efficiently embeds raw data into a low-dimensional semantic space, a local feature extraction and fusion module designed to capture and integrate multi-scale features within MS data, and a sample identification module that enhances discriminative representations to enable accurate anomaly detection. To evaluate the effectiveness of the proposed model, we conduct extensive experiments on a benchmark dataset with synthesized anomalies. Quantitative results on the benchmark dataset show that, compared with 15 baseline models from statistical learning, deep learning, and ensemble learning, our model consistently achieves the best performance across key metrics. Furthermore, through linear relationship analysis on real-world clinical datasets, the exclusion of outlier samples significantly increased the statistical significance and fold change in the identified differential proteins. Overall, the proposed model establishes a solid data foundation, paving the way for downstream mechanistic studies and target discovery.

Indexed as

Mass SpectrometryProteomicsAlgorithmsAutoencoderDeep LearningHumansQuality Controlautoencoderdeep learningfeature fusionproteomicsquality control

Identifiers

PMID41828350
PMCPMC12984335

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.